Inflammation Off-Switch: Epoxy-Oxylipins Discovery | AcademicJobs
Dive into UCL's breakthrough on epoxy-oxylipins, fat-derived molecules acting as the body's inflammation off-switch, offering new hope for arthritis, heart disease, and more.
No reviews yet. Be the first to rate Derek!
Dive into UCL's breakthrough on epoxy-oxylipins, fat-derived molecules acting as the body's inflammation off-switch, offering new hope for arthritis, heart disease, and more.
UCL scientists reveal epoxy-oxylipins as the body's inflammation off switch, reducing chronic disease risk via sEH inhibition. Key implications for RA, IBD in UK.